How Much Weight Can You Lose With Metformin: Realistic Results

Most people who take metformin lose somewhere between 2 and 7 kilograms, depending on their starting weight, how long they take it, and how consistently they use it. That range is real but modest, especially compared to the dramatic results people see with newer injectable weight-loss drugs. Metformin was designed as a blood sugar medication, and its weight effects are a side benefit rather than its primary job, which helps set expectations.

What the Numbers Actually Look Like

Clinical trials paint a fairly consistent picture. In people with type 2 diabetes, metformin typically produces a loss of roughly 2 to 4 kilograms over the first several months. One trial found a drop of about 3.8 kg over 29 weeks, while a longer four-year study reported 2.7 kg of weight loss in metformin-treated patients, even as people on other diabetes drugs gained weight during the same period.¹ Those numbers feel small on paper, but the comparison matters: the fact that metformin users lost weight while people on similar medications gained several kilograms makes the net difference meaningful.

In people with obesity who do not have diabetes, the results tend to be somewhat larger. A study of non-diabetic individuals with obesity found an average loss of about 5.8 kg, while untreated controls gained weight slightly.² A separate retrospective study found that weight loss at six months was around 6.5 kg regardless of whether patients had diabetes or not, and at 12 months it climbed to roughly 7.3 to 7.4 kg in both groups.³ That study is encouraging because it suggests you do not need to be diabetic or prediabetic to see results from metformin, but it also reflects a population that was being actively managed, not just handed a prescription.

So the realistic range for most adults is roughly 2 to 8 kilograms over the first 6 to 12 months. Where you land in that range depends on factors like your insulin resistance, your starting weight, whether you change your diet alongside the medication, and how faithfully you take it.

Adherence Is the Biggest Variable

One of the strongest findings across metformin studies is that results track closely with how consistently people actually take the drug. In the Diabetes Prevention Program, people who were highly adherent experienced an average body mass reduction of about 3.5%, while those with low adherence were essentially weight-neutral over two years.¹ That gap is enormous for a medication with otherwise modest effects.

The reason adherence can be difficult is that metformin is famously hard on the stomach, especially in its standard immediate-release form. Nausea, diarrhea, bloating, and cramping drive a meaningful number of people to skip doses or quit altogether. The extended-release version has been shown to produce fewer gut side effects and better treatment satisfaction, which makes a practical difference over months and years of use.⁴ If you have tried metformin and dropped it because of stomach issues, it is worth asking about switching to extended-release before writing the medication off entirely.

Does the Weight Stay Off Long-Term?

This is where metformin has an underappreciated advantage. The Diabetes Prevention Program Outcomes Study followed participants for 15 years and found that people who stayed on metformin maintained a weight loss of about 6.2% relative to their baseline, which was actually greater than the loss maintained by people in the intensive lifestyle-change group (about 3.7%).⁵ That is a surprising finding: at 15 years, the pill beat the diet-and-exercise program for sustained weight loss, though both groups had shed the most weight earlier and then partially regained.

Even at the 10-year mark, weight loss remained significantly greater in metformin users compared to placebo, and the effect was clearly tied to continued use of the drug.⁶ So the weight effect is durable as long as you keep taking it, which raises an obvious question about what happens if you stop.

What Happens When You Stop

Weight tends to come back. A study tracking women with polycystic ovary syndrome (PCOS) found that after stopping metformin, those who had only been on it short-term gained a significant amount of weight, going from a median of 92 kg to 96 kg.⁷ Long-term users also trended upward after stopping, though the rebound was less dramatic. This mirrors the broader pattern with weight-loss medications: the drug does not “fix” something permanently. It changes the conditions under which your body manages weight, and removing it lets the old conditions reassert themselves.

This does not mean metformin must be taken forever. But it does mean you should plan for what comes next. If metformin has helped you reach a lower weight, maintaining that loss after discontinuation requires picking up the slack with diet, physical activity, or both.

How Metformin Actually Causes Weight Loss

Metformin was not designed for weight loss, and researchers have been piecing together why it happens for years. The mechanism turns out to be more complex than anyone initially thought, involving multiple pathways rather than a single neat explanation.⁸

One important piece of the puzzle is a hormone called GDF15. Two independent randomized trials showed that metformin raises levels of this hormone, which acts on receptors in the brainstem to reduce appetite and food intake.⁹ This helps explain why many metformin users report eating less without feeling like they are actively dieting. Some of the appetite suppression also overlaps with the GI side effects: when a drug makes food a little less appealing because your stomach is unsettled, you eat less. Whether that counts as a “mechanism” or a “side effect masquerading as one” is a matter of perspective.

Metformin also reshapes the gut microbiome. Research in people with type 2 diabetes has shown that the drug shifts gut bacteria toward species associated with bile acid metabolism and production of short-chain fatty acids, which are linked to better blood sugar control and potentially to shifts in how the body handles energy.¹⁰ These microbiome changes likely contribute to both the metabolic benefits and some of the digestive unpleasantness people experience early on.

Insulin Resistance and Who Responds Best

Not everyone loses the same amount on metformin, and the biggest predictor appears to be your degree of insulin resistance going in. The study of non-diabetic individuals with obesity found that patients with severe insulin resistance lost significantly more weight than those who were insulin-sensitive.² This makes biological sense: metformin’s primary action is improving how your body responds to insulin, so the worse that process was working before, the more room for improvement.

This also helps explain why you see such a wide range of results across different studies and individual patients. Someone with substantial insulin resistance and 40 or 50 kilograms to lose may drop 7 or 8 kg in the first year, while someone who is mildly overweight and metabolically healthy might see almost no change on the scale. If your doctor has told you that you have insulin resistance, metabolic syndrome, or prediabetes, you are in the population most likely to benefit from metformin’s weight effects.

How Age Affects Results

A meta-analysis breaking results down by age found that adults aged 40 to 56 saw the largest BMI reductions with metformin treatment, around one full BMI unit. Adolescents aged 7 to 18 also showed significant drops, averaging a decrease of about 0.8 BMI units.¹¹ Both age groups responded, but older adults got more out of it. One pediatric trial found that children on metformin lost about 4.9 kg over the study period compared to 1.7 kg in the diet-and-exercise group, though the researchers described the effects as “positive, albeit modest.”¹²

For adolescents, metformin is sometimes prescribed off-label when obesity is accompanied by signs of insulin resistance. The evidence suggests it helps, but it is not a substitute for lifestyle changes, and the expectations should be realistic: a few kilograms, not a transformation.

Metformin in PCOS

Polycystic ovary syndrome is one of the most common reasons metformin gets prescribed to people who are not diabetic. PCOS is closely tied to insulin resistance, which makes metformin a logical fit. However, a recent review noted that metformin is not effective as a first-line therapy specifically for weight loss in women with PCOS, even though it helps with other aspects of the condition like metabolic markers.¹³

In a pilot trial comparing metformin alone to metformin combined with a GLP-1 drug in women with PCOS and obesity, the metformin-only group lost about 2.5 kg, while the combination group lost about 4.5 kg.¹⁴ The takeaway for women with PCOS: metformin may nudge the scale down modestly and improve metabolic health, but if weight loss is your primary goal, you may need additional interventions.

Preventing Antipsychotic-Induced Weight Gain

One population where metformin has shown particularly clear value is people taking antipsychotic medications, which are notorious for causing substantial weight gain. Metformin is the only pharmacological option that has demonstrated effectiveness at preventing this kind of weight gain, reducing it by about 4 kg compared to controls when started at the same time as the antipsychotic.¹⁵

In a trial of people who had already gained weight on antipsychotics, metformin alone produced about a 3.2 kg loss over 12 weeks, while a placebo group gained another 3.1 kg. Combining metformin with lifestyle changes did even better, producing a loss of 4.7 kg.¹⁶ For people who need to stay on antipsychotic medications, metformin fills a gap that few other options can. In a small pilot study comparing metformin to semaglutide in this population, the difference between the two drugs was not statistically significant over 16 weeks, though semaglutide trended toward slightly more weight loss.¹⁷

Exercise Plus Metformin

You would expect that adding exercise to metformin would amplify the weight loss, and the combination does appear to improve blood sugar control more than either approach alone. A systematic review found that exercise plus metformin produced greater improvements in HbA1c and fasting glucose than either treatment individually in people with type 2 diabetes.¹⁸

But the relationship between metformin and exercise is more complicated than “more is better” when it comes to weight specifically. Some research has found that the combination does not produce clearly additive weight-loss effects, and there are even reports of an antagonistic dynamic in certain outcomes when the two are combined.¹⁹ This does not mean you should skip exercise while on metformin. Exercise delivers cardiovascular, muscular, and mental health benefits that metformin cannot replicate. It just means that the weight-loss effect of the two together may not be as straightforward as stacking them up.

Vitamin B12 and Long-Term Monitoring

If you are going to take metformin for years, there is one nutritional issue worth knowing about: it increases the risk of vitamin B12 deficiency. Data from the Diabetes Prevention Program Outcomes Study found that each additional year of metformin use raised the odds of B12 deficiency by about 13%.²⁰ A more recent large analysis found that long-term users were 67% more likely to be B12-deficient than non-users.²¹ Multiple observational studies and meta-analyses have reinforced the link, particularly at higher doses and with longer duration.²²

B12 deficiency is not something you feel right away, but over time it can cause fatigue, nerve tingling, and cognitive symptoms that are easy to attribute to aging or other causes. If you are on metformin long-term, ask your doctor to check your B12 levels periodically. A simple supplement can prevent the problem entirely.

How Metformin Compares to Newer Weight-Loss Drugs

The elephant in the room is semaglutide, tirzepatide, and the other GLP-1 receptor agonists that have dominated weight-loss headlines. These drugs produce average weight losses of 15% or more of body weight in clinical trials, which makes metformin’s 3 to 7% look modest by comparison. Metformin costs a fraction of what those drugs cost, has decades of safety data behind it, and is available as a generic tablet that does not require injections. For people who need a moderate metabolic nudge rather than aggressive weight reduction, or who cannot access or tolerate GLP-1 drugs, metformin remains a practical option.

In the specific context of antipsychotic-induced weight gain, the gap between metformin and semaglutide appears smaller than in the general obesity population. That pilot comparison found semaglutide produced about 4.5 kg of loss versus 2.9 kg for metformin over 16 weeks, and the difference was not statistically significant.¹⁷ Small study, early data, but it suggests that the newer drugs’ advantage may not be as overwhelming in every population.

Off-Label Prescribing and What to Expect From Your Doctor

Metformin is FDA-approved for type 2 diabetes, not for weight loss in people with normal blood sugar. That said, off-label prescribing of metformin for weight management is widespread, and physicians have long used it for this purpose given its safety profile and low cost.²³ If your doctor prescribes metformin for weight-related reasons and you do not have diabetes, this is not unusual or experimental. It is a judgment call based on your individual metabolic picture.

What you should expect is an honest conversation about realistic outcomes. Metformin is not going to produce the dramatic before-and-after photos you see on social media. For most people, it is more like a slow, steady drag on appetite and insulin levels that, over months, translates into a few kilograms less on the scale. Combined with dietary changes and physical activity, it can be one useful piece of a broader strategy. On its own, it is a helper, not a solution.